A rare schizophrenia risk variant of CACNA1I disrupts CaV3.3 channel activity

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Andrade, A ^a,b   Hope, J ^c   Allen, A ^c   Yorgan, V ^b   Lipscombe, D ^b   Pan, J Q ^c  

^a UNIVERSITY OF NEW HAMPSHIRE   (United States)

^b BROWN UNIVERSITY   (United States)

^c BROAD INSTITUTE OF MIT AND HARVARD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CACNA1I PROTEIN, HUMAN; CALCIUM CHANNEL T TYPE;

AMINO ACID SUBSTITUTION; GENETICS; HEK293 CELL LINE; HUMAN; METABOLISM; MISSENSE MUTATION; NERVE CELL; PATHOPHYSIOLOGY; RISK FACTOR; SCHIZOPHRENIA;

AMINO ACID SUBSTITUTION; CALCIUM CHANNELS, T-TYPE; HEK293 CELLS; HUMANS; MUTATION, MISSENSE; NEURONS; RISK FACTORS; SCHIZOPHRENIA;

EID: 84992110479     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep34233     Document Type: Article

References (65)

1. Perez-Reyes, E. Molecular physiology of low-voltage-activated t-type calcium channels. Physiol Rev 83, 117-161 (2003).
2. Lee, J. H. et al. Cloning and expression of a novel member of the low voltage-activated T-type calcium channel family. J Neurosci 19, 1912-1921 (1999).
3. Houser, C. R., Vaughn, J. E., Barber, R. P., Roberts, E. GABA neurons are the major cell type of the nucleus reticularis thalami. Brain Res 200, 341-354 (1980).
4. Liu, X. B., Murray, K. D., Jones, E. G. Low-threshold calcium channel subunit Ca(v) 3. 3 is specifically localized in GABAergic neurons of rodent thalamus and cerebral cortex. J Comp Neurol 519, 1181-1195 (2011).
5. Steriade, M. Grouping of brain rhythms in corticothalamic systems. Neuroscience 137, 1087-1106 (2006).
6. Astori, S. et al. The Ca(V)3. 3 calcium channel is the major sleep spindle pacemaker in thalamus. Proc Natl Acad Sci USA 108, 13823-13828 (2011).
7. Destexhe, A., Contreras, D., Steriade, M., Sejnowski, T. J., Huguenard, J. R. In vivo, in vitro, computational analysis of dendritic calcium currents in thalamic reticular neurons. J Neurosci 16, 169-185 (1996).
8. Huguenard, J. R., Prince, D. A. Intrathalamic rhythmicity studied in vitro: nominal T-current modulation causes robust antioscillatory effects. J Neurosci 14, 5485-5502 (1994).
9. Lee, S. E. et al. Rebound burst firing in the reticular thalamus is not essential for pharmacological absence seizures in mice. Proc Natl Acad Sci USA 111, 11828-11833 (2014).
10. Ferrarelli, F., Tononi, G. The thalamic reticular nucleus and schizophrenia. Schizophr Bull 37, 306-315 (2011).
11. Pinault, D. Dysfunctional thalamus-related networks in schizophrenia. Schizophr Bull 37, 238-243 (2011).
12. Pratt, J. A., Morris, B. J. The thalamic reticular nucleus: a functional hub for thalamocortical network dysfunction in schizophrenia and a target for drug discovery. J Psychopharmacol 29, 127-137 (2015).
13. Vukadinovic, Z. Sleep abnormalities in schizophrenia may suggest impaired trans-thalamic cortico-cortical communication: towards a dynamic model of the illness. Eur J Neurosci 34, 1031-1039 (2011).
14. Wamsley, E. J. et al. Reduced sleep spindles and spindle coherence in schizophrenia: mechanisms of impaired memory consolidation. Biol Psychiatry 71, 154-161 (2012).
15. Cross-Disorder, G. O. T. P. G. C. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 381, 1371-1379 (2013).
16. Fromer, M. et al. De novo mutations in schizophrenia implicate synaptic networks. Nature 506, 179-184 (2014).
17. Purcell, S. M. et al. A polygenic burden of rare disruptive mutations in schizophrenia. Nature 506, 185-190 (2014).
18. Samocha, K. E. et al. A framework for the interpretation of de novo mutation in human disease. Nat Genet 46, 944-950 (2014).
19. Schizophrenia, W. G. O. T. P. G. C. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421-427 (2014).
20. Curtis, D. et al. Case-case genome-wide association analysis shows markers differentially associated with schizophrenia and bipolar disorder and implicates calcium channel genes. Psychiatr Genet 21, 1-4 (2011).
21. Heyes, S. et al. Genetic disruption of voltage-gated calcium channels in psychiatric and neurological disorders. Prog Neurobiol 134, 36-54 (2015).
22. Moskvina, V. et al. Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk. Mol Psychiatry 14, 252-260 (2009).
23. Zamponi, G. W. Targeting voltage-gated calcium channels in neurological and psychiatric diseases. Nat Rev Drug Discov 15, 19-34 (2016).
24. International, S. C. et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460, 748-752 (2009).
25. Heinzen, E. L., Neale, B. M., Traynelis, S. F., Allen, A. S., Goldstein, D. B. The genetics of neuropsychiatric diseases: looking in and beyond the exome. Annu Rev Neurosci 38, 47-68 (2015).
26. Limpitikul, W. B., Dick, I. E., Ben-Johny, M., Yue, D. T. An autism-associated mutation in CaV1. 3 channels has opposing effects on voltage-and Ca(2+ )-dependent regulation. Sci Rep 6, 27235 (2016).
27. Pinggera, A. et al. CACNA1D de novo mutations in autism spectrum disorders activate Cav1. 3 L-type calcium channels. Biol Psychiatry 77, 816-822 (2015).
28. Roussos, P. et al. A role for noncoding variation in schizophrenia. Cell Rep 9, 1417-1429 (2014).
29. Yoshimizu, T. et al. Functional implications of a psychiatric risk variant within CACNA1C in induced human neurons. Mol Psychiatry 20, 162-169 (2015).
30. Zhang, X., Bailey, S. D., Lupien, M. Laying a solid foundation for Manhattan-'setting the functional basis for the post-GWAS era'. Trends Genet 30, 140-149 (2014).
31. Gulsuner, S. et al. Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network. Cell 154, 518-529 (2013).
32. Schneider-Poetsch, T. et al. Inhibition of eukaryotic translation elongation by cycloheximide and lactimidomycin. Nat Chem Biol 6, 209-217 (2010).
33. Livak, K. J., Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402-408 (2001).
34. Pan, J. Q. et al. AKT kinase activity is required for lithium to modulate mood-related behaviors in mice. Neuropsychopharmacology 36, 1397-1411 (2011).
35. Groen, J. L. et al. CACNA1B mutation is linked to unique myoclonus-dystonia syndrome. Hum Mol Genet 24, 987-993 (2015).
36. Raingo, J., Castiglioni, A. J., Lipscombe, D. Alternative splicing controls G protein-dependent inhibition of N-type calcium channels in nociceptors. Nat Neurosci 10, 285-292 (2007).
37. Castiglioni, A. J., Raingo, J., Lipscombe, D. Alternative splicing in the C-terminus of CaV2. 2 controls expression and gating of N-type calcium channels. J Physiol 576, 119-134 (2006).
38. Lipscombe, D. et al. Spatial distribution of calcium channels and cytosolic calcium transients in growth cones and cell bodies of sympathetic neurons. Proc Natl Acad Sci USA 85, 2398-2402 (1988).
39. Lipscombe, D., Kongsamut, S., Tsien, R. W. Alpha-adrenergic inhibition of sympathetic neurotransmitter release mediated by modulation of N-type calcium-channel gating. Nature 340, 639-642 (1989).
40. Gomora, J. C., Murbartian, J., Arias, J. M., Lee, J. H., Perez-Reyes, E. Cloning and expression of the human T-type channel Ca(v)3. 3: insights into prepulse facilitation. Biophys J 83, 229-241 (2002).
41. Kuryshev, Y. A., Brown, A. M., Duzic, E., Kirsch, G. E. Evaluating state dependence and subtype selectivity of calcium channel modulators in automated electrophysiology assays. Assay Drug Dev Technol 12, 110-119 (2014).
42. Migliore, M. et al. ModelDB: making models publicly accessible to support computational neuroscience. Neuroinformatics 1, 135-139 (2003).
43. Mbonye, U. R. et al. Two distinct pathways for cyclooxygenase-2 protein degradation. J Biol Chem 283, 8611-8623 (2008).
44. Tcherkezian, J. et al. Proteomic analysis of cap-dependent translation identifies LARP1 as a key regulator of 5? TOP mRNA translation. Genes Dev 28, 357-371 (2014).
45. Weiss, N., Black, S. A., Bladen, C., Chen, L., Zamponi, G. W. Surface expression and function of Cav3. 2 T-type calcium channels are controlled by asparagine-linked glycosylation. Pflugers Arch 465, 1159-1170 (2013).
46. Gurnett, C. A., De Waard, M., Campbell, K. P. Dual function of the voltage-dependent Ca2+ channel alpha 2 delta subunit in current stimulation and subunit interaction. Neuron 16, 431-440 (1996).
47. Price, M. G., Davis, C. F., Deng, F., Burgess, D. L. The alpha-amino-3-hydroxyl-5-methyl-4-isoxazolepropionate receptor trafficking regulator "stargazin" is related to the claudin family of proteins by Its ability to mediate cell-cell adhesion. J Biol Chem 280, 19711-19720 (2005).
48. Sandoval, A., Oviedo, N.,rade, A., Felix, R. Glycosylation of asparagines 136 and 184 is necessary for the alpha2delta subunitmediated regulation of voltage-gated Ca2+ channels. FEBS Lett 576, 21-26 (2004).
49. Ferrarelli, F. et al. Thalamic dysfunction in schizophrenia suggested by whole-night deficits in slow and fast spindles. Am J Psychiatry 167, 1339-1348 (2010).
50. Goder, R. et al. Impairment of sleep-related memory consolidation in schizophrenia: relevance of sleep spindles. Sleep Med 16, 564-569 (2015).
51. Manoach, D. S. et al. Reduced overnight consolidation of procedural learning in chronic medicated schizophrenia is related to specific sleep stages. J Psychiatr Res 44, 112-120 (2010).
52. Manoach, D. S. et al. Sleep spindle deficits in antipsychotic-naive early course schizophrenia and in non-psychotic first-degree relatives. Front Hum Neurosci 8, 762 (2014).
53. Lodish H. et al. Molecular Cell Biology. 4th Edition. (W. H. Freeman, New York, 2000).
54. Estevez, R., Jentsch, T. J. CLC chloride channels: correlating structure with function. Curr Opin Struct Biol 12, 531-539 (2002).
55. Gong, Q.,erson, C. L., January, C. T., Zhou, Z. Role of glycosylation in cell surface expression and stability of HERG potassium channels. Am J Physiol Heart Circ Physiol 283, H77-H84 (2002).
56. Khanna, R., Myers, M. P., Laine, M., Papazian, D. M. Glycosylation increases potassium channel stability and surface expression in mammalian cells. J Biol Chem 276, 34028-34034 (2001).
57. Riordan, J. R. Assembly of functional CFTR chloride channels. Annu Rev Physiol 67, 701-718 (2005).
58. Shi, G. et al. Beta subunits promote K+ channel surface expression through effects early in biosynthesis. Neuron 16, 843-852 (1996).
59. Akhavan, A. N-and O-linked glycosylation coordinate cell-surface localization of a cardiac potassium channel. J Physiol 589, 4647-4648 (2011).
60. Ntimbane, T. et al. Cystic fibrosis-related diabetes: from CFTR dysfunction to oxidative stress. Clin Biochem Rev 30, 153-177 (2009).
61. O'Riordan, C. R., Lachapelle, A. L., Marshall, J., Higgins, E. A., Cheng, S. H. Characterization of the oligosaccharide structures associated with the cystic fibrosis transmembrane conductance regulator. Glycobiology 10, 1225-1233 (2000).
62. Smith, J. L. et al. Trafficking-deficient hERG K+channels linked to long QT syndrome are regulated by a microtubule-dependent quality control compartment in the ER. Am J Physiol Cell Physiol 301, C75-C85 (2011).
63. Fekete, A., Johnston, J., Delaney, K. R. Presynaptic T-type Ca2+ channels modulate dendrodendritic mitral-mitral and mitralperiglomerular connections in mouse olfactory bulb. J Neurosci 34, 14032-14045 (2014).
64. Kopala, L. C., Good, K. P., Torrey, E. F., Honer, W. G. Olfactory function in monozygotic twins discordant for schizophrenia. Am J Psychiatry 155, 134-136 (1998).
65. Zuk, O. et al. Searching for missing heritability: designing rare variant association studies. Proc Natl Acad Sci USA 111, E455-E464 (2014).